Prominent Role of α3/α6β2* nAChRs in Regulating Evoked Dopamine Release in Primate Putamen: Effect of Long-Term Nicotine Treatment

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161 · see citing works

Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum

Haber, S. N., Fudge, J. L., & McFarland, N. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02369.2000 · Cited by 1,610 · see citing works

The neostriatal mosaic: multiple levels of compartmental organization

Gerfen, C. R. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90355-c · Cited by 1,471 · see citing works

Functional anatomy of the basal ganglia

Yelnik, J. (2002) · Movement Disorders · doi:10.1002/mds.10138 · Cited by 957 · see citing works

A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.

Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880 · see citing works

Guidelines on nicotine dose selection for in vivo research

Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · see citing works

Nicotine amplifies reward-related dopamine signals in striatum

Rice, M. E., & Cragg, S. J. (2004) · Nature Neuroscience · doi:10.1038/nn1244 · Cited by 594 · see citing works

Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment

Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551 · see citing works

It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood

PICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 451 · cited 3× · see citing works

Cholinergic interneuron characteristics and nicotinic properties in the striatum

Zhou, F., Wilson, C. J., & Dani, J. A. (2002) · Journal of Neurobiology · doi:10.1002/neu.10150 · Cited by 443 · see citing works

Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in Mice

Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401 · see citing works

Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey

Schultz, W. (1986) · Journal of Neurophysiology · doi:10.1152/jn.1986.56.5.1439 · Cited by 390 · cited 2× · see citing works

Frequency-dependent modulation of dopamine release by nicotine

Zhang, H., & Sulzer, D. (2004) · Nature Neuroscience · doi:10.1038/nn1243 · Cited by 361 · see citing works

Desensitization of nicotinic ACh receptors: shaping cholinergic signaling

GINIATULLIN, R., NISTRI, A., & YAKEL, J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.04.009 · Cited by 357 · see citing works

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum

Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252 · see citing works

Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission

Exley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 249 · see citing works

α6-Containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens

Exley, R., Clements, M. A., Hartung, H., McIntosh, J. M., & Cragg, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301617 · Cited by 242 · see citing works

Ca2+ Permeability of the (α4)3(β2)2 Stoichiometry Greatly Exceeds That of (α4)2(β2)3 Human Acetylcholine Receptors

Tapia, L., Kuryatov, A., & Lindstrom, J. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030445 · Cited by 196 · see citing works

Roles of Accessory Subunits in α4β2* Nicotinic Receptors

Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195 · see citing works

Striatal Responses to Partial Dopaminergic Lesion: Evidence for Compensatory Sprouting

Song, D. D., & Haber, S. N. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05102.2000 · Cited by 163 · see citing works

Nicotine and Parkinson's disease: implications for therapy

Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154 · see citing works

Chemical neuroanatomy of the basal ganglia — normal and in Parkinson's disease

Hornykiewicz, O. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00100-4 · Cited by 131 · see citing works

Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy

Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 127 · see citing works

Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels

Pauly, J. R., Marks, M. J., Robinson, S. F., van de Kamp, J. L., & Collins, A. C. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20143-4 · Cited by 126 · see citing works

Dopamine Release and Uptake Dynamics within Nonhuman Primate StriatumIn Vitro

Cragg, S. J., Hille, C. J., & Greenfield, S. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-21-08209.2000 · Cited by 120 · see citing works

Nicotinic receptors as CNS targets for Parkinson's disease

Quik, M., Bordia, T., & O’Leary, K. T. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.015 · Cited by 116 · see citing works

Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant α7 and α4β2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes

Coates, K., & Flood, P. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704315 · Cited by 114 · see citing works

Long-Term Nicotine Treatment Decreases Striatal α6* Nicotinic Acetylcholine Receptor Sites and Function in Mice

Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112 · see citing works

Nigrostriatal Damage Preferentially Decreases a Subpopulation of α6β2* nAChRs in Mouse, Monkey, and Parkinson’s Disease Striatum

Bordia, T., Grady, S. R., McIntosh, J. M., & Quik, M. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035998 · Cited by 97 · see citing works

Nicotinic α5 subunit deletion locally reduces high‐affinity agonist activation without altering nicotinic receptor numbers

Brown, R. W. B., Collins, A. C., Lindstrom, J. M., & Whiteaker, P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04700.x · Cited by 88 · cited 1× · see citing works

Subunit Composition of Nicotinic Receptors in Monkey Striatum: Effect of Treatments with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA

Quik, M., Vailati, S., Bordia, T., Kulak, J. M., Fan, H., McIntosh, J. M., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006015 · Cited by 86 · see citing works

Non-Agonist-Binding Subunit Interfaces Confer Distinct Functional Signatures to the Alternate Stoichiometries of the 4 2 Nicotinic Receptor: An 4- 4 Interface Is Required for Zn2+ Potentiation

Moroni, M., Vijayan, R., Carbone, A. L., Zwart, R., Biggin, P. C., & Bermúdez, I. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1228-08.2008 · Cited by 81 · see citing works

Chronic Oral Nicotine Normalizes Dopaminergic Function and Synaptic Plasticity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Primates

Quik, M., Chen, L., Parameswaran, N., Xie, X., Langston, J. W., & McCallum, S. E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0215-06.2006 · Cited by 77 · see citing works

Long-term nicotine treatment differentially regulates striatal α6α4β2* and α6(nonα4)β2* nAChR expression and function

Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77 · see citing works

Pre‐synaptic dopaminergic compensation after moderate nigrostriatal damage in non‐human primates

Perez, X. A., Parameswaran, N., Huang, L. Z., O’Leary, K. T., & Quik, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05268.x · Cited by 70 · see citing works

Functional Domains in Dorsal Striatum of the Nonhuman Primate Are Defined by the Dynamic Behavior of Dopamine

Cragg, S. J., Hille, C. J., & Greenfield, S. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05705.2002 · Cited by 66 · see citing works

The neuronal nicotinic acetylcholine receptors α4* and α6* differentially modulate dopamine release in mouse striatal slices

Meyer, E. L., Yoshikami, D., & McIntosh, J. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05266.x · Cited by 58 · see citing works

Increases in α4* but not α3*/α6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment

McCallum, S. E., Parameswaran, N., Bordia, T., Fan, H., Tyndale, R. F., Langston, J. W., McIntosh, J. M., & Quik, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03646.x · Cited by 44 · see citing works

Compensation in pre‐synaptic dopaminergic function following nigrostriatal damage in primates

McCallum, S. E., Parameswaran, N., Perez, X. A., Bao, S., McIntosh, J. M., Grady, S. R., & Quik, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03610.x · Cited by 37 · see citing works

REGIONAL CHANGES IN BRAIN CATECHOLAMINES AFTER PROTON IRRADIATION OF THE STRIATE CORTEX IN THE SQUIRREL MONKEY

Hsu, L. L., Samorajski, T., Ordy, J. M., Bose, H., & Curtis, H. J. (1971) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1971.tb03746.x · Cited by 9 · see citing works

Structural and functional diversity of native brain neuronal nicotinic receptors

Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469 · see citing works

Smoking, nicotine and neuropsychiatric disorders

Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works

α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease

Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 194 · see citing works

Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions

Gonzales, K. K., & Smith, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12762 · Cited by 164 · see citing works

Withdrawal from Chronic Nicotine Exposure Alters Dopamine Signaling Dynamics in the Nucleus Accumbens

Zhang, L., Dong, Y., Doyon, W. M., & Dani, J. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.024 · Cited by 135 · see citing works

Multiple roles for nicotine in Parkinson's disease

Quik, M., Huang, L. Z., Parameswaran, N., Bordia, T., Campos, C., & Perez, X. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.003 · Cited by 134 · see citing works

Treatment strategies for Parkinson’s disease

Yuan, H., Zhang, Z., Liang, L.-W., Shen, Q., Wang, X.-D., Ren, S.-M., Ma, H., Jiao, S.-J., & Liu, P. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-0302-z · Cited by 96 · see citing works

α-Conotoxin MII-Sensitive Nicotinic Acetylcholine Receptors in the Nucleus Accumbens Shell Regulate Progressive Ratio Responding Maintained by Nicotine

Brunzell, D. H., Boschen, K. E., Hendrick, E. S., Beardsley, P. M., & McIntosh, J. M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.171 · Cited by 95 · see citing works

Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders

Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 94 · see citing works

Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats

Huang, L. Z., Campos, C., Ly, J., Carroll, F. I., & Quik, M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.032 · Cited by 73 · see citing works

Nicotinic receptors regulate the dynamic range of dopamine release in vivo

Koranda, J. L., Cone, J. J., McGehee, D. S., Roitman, M. F., Beeler, J. A., & Zhuang, X. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00269.2013 · Cited by 62 · see citing works

Severe drug-induced repetitive behaviors and striatal overexpression of VAChT in ChAT-ChR2-EYFP BAC transgenic mice

Crittenden, J. R., Lacey, C. J., Lee, T., Bowden, H. A., & Graybiel, A. M. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00057 · Cited by 57 · see citing works

α6β2* and α4β2* Nicotinic Receptors Both Regulate Dopamine Signaling with Increased Nigrostriatal Damage: Relevance to Parkinson’s Disease

Perez, X. A., Bordia, T., McIntosh, J. M., & Quik, M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.067561 · Cited by 57 · see citing works

Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease

Schaeffer, E., Pilotto, A., & Berg, D. (2014) · CNS Drugs · doi:10.1007/s40263-014-0205-z · Cited by 54 · see citing works

Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity α4β2 subunit combination

Anderson, D. J., Malysz, J., Grønlien, J. H., El Kouhen, R., Håkerud, M., Wetterstrand, C., Briggs, C. A., & Gopalakrishnan, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.024 · Cited by 44 · see citing works

Long-Term Nicotine Exposure Depresses Dopamine Release in Nonhuman Primate Nucleus Accumbens

Perez, X. A., Ly, J., McIntosh, J. M., & Quik, M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194084 · Cited by 43 · see citing works

Significant associations of CHRNA2 and CHRNA6 with nicotine dependence in European American and African American populations

Wang, S., van der Vaart, A. D., Xu, Q., Seneviratne, C., Pomerleau, O. F., Pomerleau, C. S., Payne, T. J., Ma, J. Z., & Li, M. D. (2013) · Human Genetics · doi:10.1007/s00439-013-1398-9 · Cited by 40 · see citing works

Striatal dopamine transmission is reduced after chronic nicotine with a decrease in α6‐nicotinic receptor control in nucleus accumbens

Exley, R. A., Clements, M. A., Hartung, H., McIntosh, J. M., Franklin, M., Bermúdez, I., & Cragg, S. J. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12298 · Cited by 40 · see citing works

α6β2*‐subtype nicotinic acetylcholine receptors are more sensitive than α4β2*‐subtype receptors to regulation by chronic nicotine administration

Marks, M. J., Grady, S. R., Salminen, O., Paley, M. A., Wageman, C. R., McIntosh, J. M., & Whiteaker, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12721 · Cited by 37 · see citing works

Targeting Nicotinic Receptors for Parkinson's Disease Therapy

Quik, M., Bordia, T., Huang, L. Z., & Perez, X. A. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711797247849 · Cited by 37 · see citing works

Preclinical Evidence That Activation of Mesolimbic Alpha 6 Subunit Containing Nicotinic Acetylcholine Receptors Supports Nicotine Addiction Phenotype

Brunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 32 · see citing works

Enhanced synthesis and release of dopamine in transgenic mice with gain‐of‐function α6* nAChR s

Wang, Y., Lee, J., Oh, G., Grady, S. R., McIntosh, J. M., Brunzell, D. H., Cannon, J. R., & Drenan, R. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12616 · Cited by 29 · see citing works

bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse

Wooters, T. E., Smith, A. M., Pivavarchyk, M., Siripurapu, K. B., McIntosh, J. M., Zhang, Z., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01220.x · Cited by 28 · see citing works

A high-sensitive nano-modified biosensor for dynamic monitoring of glutamate and neural spike covariation from rat cortex to hippocampal sub-regions

Xiao, G., Song, Y., Zhang, S., Yang, L., Xu, S., Zhang, Y., Xu, H., Gao, F., Li, Z., & Cai, X. (2017) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2017.08.015 · Cited by 27 · see citing works

Long‐term nicotine treatment down‐regulates α6β2* nicotinic receptor expression and function in nucleus accumbens

Perez, X. A., McIntosh, J. M., & Quik, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12442 · Cited by 27 · see citing works

Crucial roles of the CHRNB3–CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research

Wen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 26 · see citing works

The nicotine‐mediated decline in l ‐dopa‐induced dyskinesias is associated with a decrease in striatal dopamine release

Bordia, T., McIntosh, J. M., & Quik, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12179 · Cited by 23 · see citing works

Phasic Dopamine Release Magnitude Tracks Individual Differences in Sensitization of Locomotor Response following a History of Nicotine Exposure

Fennell, A. M., Pitts, E. G., Sexton, L. L., & Ferris, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-019-56884-z · Cited by 21 · see citing works

r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement

Beckmann, J. S., Meyer, A. C., Pivavarchyk, M., Horton, D. B., Zheng, G., Smith, A. M., Wooters, T. E., McIntosh, J. M., Crooks, P. A., Bardo, M. T., et al. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1680-4 · Cited by 17 · see citing works

Chronic co-administration of nicotine and methamphetamine causes differential expression of immediate early genes in the dorsal striatum and nucleus accumbens of Rats

Saint-Preux, F., Bores, L. R., Tulloch, I., Ladenheim, B., Kim, R., Thanos, P. K., Volkow, N. D., & Cadet, J. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.052 · Cited by 17 · see citing works

Repeated nicotine administration robustly increases bPiDDB inhibitory potency at α6β2-containing nicotinic receptors mediating nicotine-evoked dopamine release

Smith, A. M., Pivavarchyk, M., Wooters, T. E., Zhang, Z., Zheng, G., McIntosh, J. M., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.018 · Cited by 15 · see citing works

Sympathetic α3β2-nAChRs mediate cerebral neurogenic nitrergic vasodilation in the swine

Lee, R. H., Liu, Y.-Q., Chen, P.-Y., Liu, C., Chen, M.-F., Lin, H.-W., Kuo, J., Premkumar, L. S., & Lee, T. J.-F. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00172.2011 · Cited by 13 · see citing works

A Critical Review of Repurposing Apomorphine for Smoking Cessation

Morales‐Rosado, J. A., Cousin, M. A., Ebbert, J. O., & Klee, E. W. (2015) · Assay and Drug Development Technologies · doi:10.1089/adt.2015.680 · Cited by 11 · see citing works

Significant, replicable, and functional associations between KTN1 variants and alcohol and drug codependence

Luο, X., Guo, X., Luo, X., Tan, Y., Zhang, P., Yang, K., Xie, T., Shi, J., Zhang, Y., Xu, J., et al. (2020) · Addiction Biology · doi:10.1111/adb.12888 · Cited by 8 · see citing works

Nicotine Dependence and the CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome

Lee, S., Barrie, E. S., Sadée, W., & Smith, R. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00043-5 · Cited by 2 · see citing works

Contribution of Variants in CHRNB3/A6 Gene Cluster on Chromosome 8 to Smoking Dependence

Li, M. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-7530-8_6 · Cited by 1 · see citing works

A Role for Neuronal Nicotinic Acetylcholine Receptors in Dopamine-Mediated Behaviors and the Hypnotic Response to Anesthetics: A Dissertation

Soll, L. G. (2013) · eScholarship@UMassChan · doi:10.13028/m2ng64

A Role for Nicotine in Neuroprotection Against Disorders Associated With Monoaminergic and Cognitive Dysfunction

de Lima Vieira Brock, P. (2019) · J. Willard Marriott Library · doi:10.26053/0j-t9x7-v964

Prominent Role of 3/62 * nAChRs in Regulating Evoked Dopamine Release in Primate Putamen: Effect of Long-Term Nicotine Treatment

Perez, X. A., O’Leary, K. T., Parameswaran, N., & McIntosh, J. M. (2008)

MOL #53801 1 TITLE PAGE

Perez, X. A., O’Leary, K. T., Parameswaran, N., & Mcintosh, J. M. (2016)

Differential Regulation of Mesolimbic α3 /α6β2 and α4β2 Nicotinic Acetylcholine Receptor Sites and Function after Long-Term Oral Nicotine to Monkeys

McCallum, S. E., Parameswaran, N., Bordia, T., Fan, H., McIntosh, J. M., & Quik, M. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104414 · Cited by 48 · see citing works

Striatal dopamine transmission is reduced after chronic nicotine with a decrease in α6‐nicotinic receptor control in nucleus accumbens

Exley, R. A., Clements, M. A., Hartung, H., McIntosh, J. M., Franklin, M., Bermúdez, I., & Cragg, S. J. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12298 · Cited by 40 · see citing works

Long-term nicotine treatment differentially regulates striatal α6α4β2* and α6(nonα4)β2* nAChR expression and function

Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77 · see citing works